Menu
Login
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
Treating Psoriasis with Phototherapy
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
1800 Diagonal Road, Suite 360
Alexandria, VA 22314
General Information
Active Dates
Wednesday, January 12, 2022 - Friday, January 12, 2024
Estimated Completion Time
30 minutes
Conference Host
National Psoriasis Foundation
Conference Location
Virtual Conference Room
Conference Name
Psound Bytes CME Podcast
Provider
National Psoriasis Foundation
Watch this Lecture Remotely
Objectives
Event Objectives
Have a better understanding of using phototherapy to manage psoriasis
Presentations and Speakers
Presentation #1
Treating Psoriasis with Phototherapy
Joel Gelfand, MD
Available Credits/Points
Credit Designation
The National Psoriasis Foundation designates this enduring material for a maximum of 0.5
AMA PRA Category 1 Credits
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Description
Hear Dr. Joel Gelfand, Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit and Director, Psoriasis and Phototherapy Treatment Center, discuss the use of phototherapy as a treatment for psoriasis and give us an update on the LITE Study.
This program is supported by educational grants from AbbVie, Novartis, Pfizer and UCB.
Disclosure Statements
Series Disclosures
NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Event Disclosures
Speakers:
Joel Gelfand, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
Abbvie, BMS, Boehringer Ingelheim, Celldex, FIDE, GSK, Happify, Lilly , Leo, Janssen Biologics, Neumentum, Novartis Corp, Pfizer, UCB, Neuroderm, Regeneron, Trevi, and Mindera DX - Consulting - Relationship Has Not Ended
Boehringer Ingelheim, and Pfizer Inc - Contracted Research - Relationship Has Not Ended
resiquimod - co-patent holder - Relationship Has Not Ended
Commercial Support
Support for this activity is gratefully acknowledged from Amgen. Support for this activity is gratefully acknowledged from Novartis. Support for this activity is gratefully acknowledged from Pfizer. Support for this activity is gratefully acknowledged from UCB.
Accreditation Statement
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
Percentage of Correct Responses Required to Pass
0 %
Percentage of Responses Required to Submit
100 %
Last Review Date
1/12/2022
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement